Irinotecan liposome injection

Irinotecan liposome injection

FDA approved irinotecan liposome injection (ONIVYDE, Merrimack Pharmaceuticals, Inc.), administered in combination with fluorouracil (5FU) and leucovorin (LV), for the treatment ofpatients with metastatic adenocarcinoma of the pancreas whose disease has progressed following gemcitabine-based therapy. October 22, 2015. More Information: http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm468728.htm

FDA Logo

Advertisements